IP Library Granted Patent US 10,076,649
Granted Patent B2
US 10,076,649 · App. 14/342,554 · Granted Sep 18, 2018

Delivery system for hollow microneedle arrays

Inventors: Thomas J. Gilbert (St. Paul, MN); Chin-Yee Ng (Oakdale, MN); Scott A. Burton (Woodbury, MN); Michael C. Molinet (Palo Alto, CA); Robert A. Harkins (Savage, MN); Bernard A. Gonzalez (St. Paul, MN); Larry A. Schleif (Monticello, MN); Patrick J. Young (Minneapolis, MN)
Assignee: 3M Innovative Properties Company
A61M37/0015A61M5/14248A61M5/1454A61M2005/1585A61M2037/003A61M2037/0023A61M2037/0061
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,076,649
App. No.
14/342,554
Granted
Sep 18, 2018
Kind
B2
Abstract

Systems and methods for delivering microneedles to a patient's skin are described. In one aspect, a system for delivering a microneedle array to a patient's skin surface is provided. The system includes a delivery apparatus with a housing, and an infusion device detachably received in the housing.

Claims (50)

1. A system for delivering a microneedle array to a patient's skin surface, the system comprising:

a delivery apparatus comprising a housing comprising an upper housing pivotably attached to a lower housing; and

an infusion device detachably received in the housing, the infusion device including;

a reservoir having a fluid therein and an openable end including a first major surface,

a fluid pathway proximate the openable end,

a first stored energy device proximate the reservoir actuatable to apply energy in a direction perpendicular to the first major surface, and

an attachment surface and an array of hollow microneedles coupled to a portion of the attachment surface, wherein the pathway is in fluid communication with the hollow microneedles

wherein the housing is configured to provide for the infusion device replacement.

2. The system of claim 1 , wherein the reservoir is a drug cartridge releasably received in a chamber proximate the first stored energy device.

3. The system of claim 1 , wherein the drug cartridge comprises a piston and a septum proximate the openable end.

4. The system of claim 3 , wherein the first stored energy device is operable to move the septum into contact with a piercing needle in fluid communication with the pathway.

5. The system of claim 3 , wherein the first stored energy device is operable to drive the piston so as to transfer the fluid from the reservoir to the pathway.

6. The system of claim 3 , wherein the first stored energy device comprises a first spring operable to drive the cartridge in a direction parallel to the array and a second spring operable to move the piston within the cartridge.

7. The system of claim 1 , the system further comprising a second stored energy device coupled to the upper housing and in contact with the infusion device.

8. The system of claim 7 , wherein the second stored energy device is operable to apply energy in a direction orthogonal to the major plane of the array, said energy applied to a surface of the infusion device remote from the array.

9. The system of claim 7 , wherein the second stored energy device is operable to drive the infusion device at a velocity of at least 2 and no greater than about 20 m/sec.

10. The system of claim 7 , wherein the second stored energy device is not attached to the infusion device.

11. The system of claim 7 , wherein the first and second stored energy devices are comprised of at least one stored energy device from a group consisting of: spring devices, gaseous propellants, chemicals, electrical devices, and combinations thereof.

12. The system of claim 1 , wherein the first stored energy device is actuatable to apply energy in a direction parallel to the major plane of the array.

13. The system of claim 1 , wherein the infusion device comprises a releasable adhesive layer disposed on at least a portion of the attachment surface.

14. The system of claim 13 , wherein the releasable adhesive layer is disposed on portion of a first major surface of the array.

15. The system of claim 14 , wherein first stored energy device comprises a propellant canister, and wherein reservoir comprises a drug cartridge having a cylindrical housing, a piston, and a valve.

16. The system of claim 15 , wherein the piston comprises a recess and wherein the canister is received in the recess.

17. The system of claim 1 , wherein the first stored energy device is actuatable to transfer force in a certain direction along an axis perpendicular to the major plane of the array.

18. The system of claim 1 , wherein the reservoir includes a transparent portion and infusion device includes a portion that allows for inspection of the transparent portion of the reservoir.

19. The system of claim 1 , the system further including a second stored energy device, wherein the housing includes a single actuator operably connected to both the first and second stored energy devices and being actuatable to actuate the first and second stored energy devices.

20. The system of claim 1 , wherein the infusion device comprises an actuator coupled to the first stored energy device.

21. The system of claim 1 , wherein the array of hollow microneedles includes a spacing density of at least 3 and no greater than 18 microneedles per square centimeter.

22. The system of claim 1 , wherein the upper housing is hingedly connected to the lower housing.

23. The system of claim 22 , wherein the delivery apparatus comprises a second stored energy device, and wherein the second stored energy device is operable to direct an activation energy to the infusion device subsequent application of a force normal to a portion of the upper housing.

24. The system of claim 1 , wherein the reservoir comprises a drug cartridge, wherein the cartridge is disposed in a recess in the infusion device, said recess located proximate the array along an axis perpendicular to the major plane of the array.

25. The system of claim 1 , wherein the reservoir comprises a drug cartridge, and wherein the cartridge is disposed in a recess within the infusion device, said recess located proximate the array along an axis parallel to the major plane of the array.

26. The system of claim 1 , wherein the infusion device comprises a height no greater than 2 cm.

27. A method comprising:

providing the integrated system of claim 1 ,

displacing the infusion device in a direction perpendicular to the major plane of the array;

establishing fluid communication between the openable end of the reservoir and the pathway;

detaching the infusion device from the housing; and

forcing fluid from the reservoir into the microneedle array through the pathway.

28. The system of claim 1 , wherein the lower housing comprises a base defining an opening.

29. The system of claim 1 , wherein the infusion device is configured to provide for the reservoir replacement.

30. A system for delivering a microneedle array to a patient's skin surface, the system comprising:

a delivery apparatus comprising a housing; and

an infusion device detachably received in the housing, the infusion device including;

a reservoir having a fluid therein and an openable end including a first major surface,

a fluid pathway proximate the openable end,

a first stored energy device proximate the reservoir actuatable to apply energy in a direction perpendicular to the first major surface,

an attachment surface and an array of hollow microneedles coupled to a portion of the attachment surface, wherein the pathway is in fluid communication with the hollow microneedles, and

a reservoir housing receiving the reservoir and the first stored energy source and the reservoir housing is between the reservoir and the housing

wherein the housing is configured to provide for the infusion device replacement.

Assignments (5)
SECURITY INTEREST Recorded Dec 14, 2022
From: KINDEVA DRUG DELIVERY L.P.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 062122/0618 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED AT R/F 053586/0715 Recorded Dec 12, 2022
From: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 062115/0707 →
SECURITY INTEREST Recorded Aug 24, 2020
From: KINDEVA DRUG DELIVERY L.P.
To: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
Reel/Frame 053586/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2020
From: 3M COMPANY; 3M INNOVATIVE PROPERTIES COMPANY
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 052818/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2014
From: GILBERT, THOMAS J.; NG, CHIN-YEE; BURTON, SCOTT A.; MOLINET, MICHAEL C.; HARKINS, ROBERT A.; GONZALEZ, BERNARD A.; SCHLEIF, LARRY A.; YOUNG, PATRICK J.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 032342/0077 →
Continuity (2)
Provisional Application 61531843 · Sep 7, 2011
Related Publication 20140243786A1 · Aug 28, 2014
Cited By (3)
US 12,214,346 US 12,440,133 US 12,446,810